Study of CEP-701 (Lestaurtinib) in Patients With Acute Myeloid Leukemia (AML)

NCT00079482 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

224

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Myeloid Leukemia

Interventions

DRUG: CEP-701
DRUG: high-dose cytarabine
DRUG: Mitozantrone, Etoposide, Cytarabine (combination Chemotherapy)

Sponsor

Cephalon